April 10, 2018 / 11:34 AM / 14 days ago

BRIEF-Biocryst Pharmaceuticals And Idera Pharmaceuticals Reschedule Meetings To Vote On Proposed Merger

April 10 (Reuters) - Idera Pharmaceuticals Inc - New Clinical Data On Idera’s Imo :

* BIOCRYST PHARMACEUTICALS AND IDERA PHARMACEUTICALS RESCHEDULE MEETINGS TO VOTE ON PROPOSED MERGER

* BIOCRYST AND IDERA SPECIAL MEETINGS TO BE HELD ON JULY 10, 2018

* NEW CLINICAL DATA ON IDERA’S IMO-2125 PROGRAM WILL BE AVAILABLE PRIOR TO VOTE

* IDERA BOARD UNANIMOUSLY RECOMMENDS THAT IDERA STOCKHOLDERS VOTE “FOR” PROPOSED MERGER AT IDERA SPECIAL MEETING Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below